The tyrosine phosphatase Shp2 in development and cancer

Katja S Grossmann1, Marta Rosário, Carmen Birchmeier

  • 1Department of Cancer Research, Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany.

Insights

Shp2 tyrosine phosphatase mutations cause developmental disorders like Noonan syndrome and cancers such as juvenile myelomonocytic leukemia. Understanding Shp2's role in signaling pathways is key to disease mechanisms.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Shp2 tyrosine phosphatase regulates receptor tyrosine kinase (RTK) and cytokine receptor signaling.
  • Germline mutations in the PTPN11 gene (encoding Shp2) are linked to Noonan (NS) and LEOPARD syndromes.
  • Somatic Shp2 mutations are implicated in human malignancies, including juvenile myelomonocytic leukemia (JMML).

Purpose of the Study:

  • To elucidate the role of Shp2 in signaling pathways.
  • To understand the mechanisms of Shp2 in embryonic development and tumorigenesis.
  • To investigate the link between Shp2 mutations and human diseases.

Main Methods:

  • Analysis of germline and somatic mutations in the PTPN11 gene.
  • Utilizing animal models with conditional gain-of-function (GOF) and loss-of-function (LOF) Shp2 mutations.
  • Studying Shp2's function in receptor tyrosine kinase and cytokine receptor signaling pathways.

Main Results:

  • Gain-of-function (GOF) Shp2 mutations cause Noonan syndrome and JMML.
  • Loss-of-function (LOF) Shp2 mutations are associated with LEOPARD syndrome.
  • Animal models demonstrate Shp2's critical role in embryonic development and cellular transformation.

Conclusions:

  • Shp2 is a crucial regulator of signaling pathways involved in development and cancer.
  • Understanding Shp2's function is vital for developing therapies for Shp2-associated diseases.
  • Conditional mutation models provide insights into Shp2's dual role in development and disease.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...